GSK trumpets Jemperli vs Keytruda data in first-line NSCLC GSK says its PD-1 inhibitor Jemperli compared favourably with Merck & Co’s Keytruda in a head-to-head trial in Share X GSK trumpets Jemperli vs Keytruda data in first-line NSCLC https://pharmaphorum.com/news/gsk-trumpets-jemperli-vs-keytruda-data-in-first-line-nsclc/
Ex-Theranos exec Sunny Balwani gets 13 years for fraud Ramesh “Sunny” Balwani, the former business partner of Theranos founder Elizabeth Holmes, has been sentenced to nearly 13 Share X Ex-Theranos exec Sunny Balwani gets 13 years for fraud https://pharmaphorum.com/news/ex-theranos-exec-sunny-balwani-gets-13-years-for-fraud/
NHS Health Check to be digitised to ease GP pressure A digital version of the NHS Health Check for 40- to 74-year-olds is to be piloted by the Share X NHS Health Check to be digitised to ease GP pressure https://pharmaphorum.com/news/nhs-health-check-to-be-digitised-to-ease-gp-pressure/
Continuing to keep COVID-19 at bay – the pharmaphorum podcast Flying into London recently for the Jefferies Conference, Novavax’s EVP, chief commercial officer, and chief business officer John Share X Continuing to keep COVID-19 at bay – the pharmaphorum podcast https://pharmaphorum.com/r-d/continuing-to-keep-covid-19-at-bay/
The mysterious UK Life Sciences Council Just as the life sciences industry is getting vocal about how it’s faring, given the prospect of having Share X The mysterious UK Life Sciences Council https://pharmaphorum.com/views-and-analysis/the-mysterious-uk-life-sciences-council/
How eligible patient numbers affect price of rare disease drugs in France Having recently assessed the relationship between drug price and prevalence of non-oncology rare diseases, CRA’s Life Sciences Practice Share X How eligible patient numbers affect price of rare disease drugs in France https://pharmaphorum.com/views-and-analysis/how-eligible-patient-numbers-affect-price-of-rare-disease-drugs-in-france/
Deep Dive: Digital Health 2022 Following an unprecedented year of surging investment interest, the digital health industry is booming. With myriad new technologies Share X Deep Dive: Digital Health 2022 https://pharmaphorum.com/digital/deep-dive-digital-health-2022/
The story behind the numbers: how burden of illness studies add value to HTA submissions In a time of increasing cost pressures, limited resource capacity, and heightened demand for new treatments, Health Technology Share X The story behind the numbers: how burden of illness studies add value to HTA submissions https://pharmaphorum.com/patients/the-story-behind-the-numbers-how-burden-of-illness-studies-add-value-to-hta-submissions/
Endometriosis: hidden suffering and disease burden Improving patient outcomes starts by listening to and understanding their needs. Research Partnership’s Living With reports give a Share X Endometriosis: hidden suffering and disease burden https://pharmaphorum.com/patients/endometriosis-hidden-suffering-and-disease-burden/
Meeting MSL training needs in an evolving landscape Share X Meeting MSL training needs in an evolving landscape https://pharmaphorum.com/oncology/meeting-msl-training-needs-in-an-evolving-landscape/
Measuring the intangible – what is the true value of a “patient centric” initiative Share X Measuring the intangible – what is the true value of a “patient centric” initiative https://pharmaphorum.com/patients/what-is-the-true-value-of-a-patient-centric-initiative/
Innovative Medicines Fund and the opportunity for ICSs to mobilise NICE approvals Share X Innovative Medicines Fund and the opportunity for ICSs to mobilise NICE approvals https://pharmaphorum.com/webinars/innovative-medicines-fund-and-the-opportunity-for-icss-to-mobilise-nice-approvals/
Unlocking the full power of data for Pharma The value of data has never been greater in healthcare. With greater digital engagement and opportunities available as Share X Unlocking the full power of data for Pharma https://pharmaphorum.com/sales-marketing/unlocking-the-full-power-of-data-for-pharma/
Pharma’s New Frontier MSLs are in prime position to build new structures of engagement as the pharma industry recalibrates after the Share X Pharma’s New Frontier https://pharmaphorum.com/sales-marketing/pharmas-new-frontier/
Ensuring successful digital outreach and retention in atopic dermatitis trials Trial organisers face intense competition to find and recruit eligible patients for atopic dermatitis studies. With more than Share X Ensuring successful digital outreach and retention in atopic dermatitis trials https://pharmaphorum.com/whitepapers/ensuring-successful-digital-outreach-and-retention-atopic-dermatitis-trials/
Continuing to keep COVID-19 at bay – the pharmaphorum podcast Share X Continuing to keep COVID-19 at bay – the pharmaphorum podcast https://pharmaphorum.com/r-d/continuing-to-keep-covid-19-at-bay/
Health Innovators – Monique Levy Share X Health Innovators – Monique Levy https://pharmaphorum.com/digital/health-innovators-monique-levy/
Can VR technology make physical therapy fun? – the pharmaphorum podcast Share X Can VR technology make physical therapy fun? – the pharmaphorum podcast https://pharmaphorum.com/digital/can-vr-technology-make-physical-therapy-fun/
Role of KOL influence Share X Role of KOL influence https://pharmaphorum.com/partner-content/role-of-kol-influence/
Illuminating Real-Time Patient Needs Through Socially Driven Insights Share X Illuminating Real-Time Patient Needs Through Socially Driven Insights https://pharmaphorum.com/partner-content/illuminating-real-time-patient-needs-through-socially-driven-insights/
Is pharma marketing built on straw, sticks, or bricks? Share X Is pharma marketing built on straw, sticks, or bricks? https://pharmaphorum.com/news/is-pharma-marketing-built-on-straw-sticks-or-bricks/
Applying a payer lens to your early pipeline planning Share X Applying a payer lens to your early pipeline planning https://pharmaphorum.com/partner-content/applying-a-payer-lens-to-your-early-pipeline-planning/
AXON hires a Global Healthcare Insights and Strategy Lead Share X AXON hires a Global Healthcare Insights and Strategy Lead https://pharmaphorum.com/partner-content/axon-hires-a-global-healthcare-insights-and-strategy-lead/
Performance-io hires Lonneke Feskens to lead Europe Share X Performance-io hires Lonneke Feskens to lead Europe https://pharmaphorum.com/partner-content/performance-io-hires-lonneke-feskens-to-lead-europe/
